US Bancorp’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,241
| Closed | -$19.5K | – | 4112 |
|
|
2024
Q1 | $19.5K | Sell |
1,241
-103
| -8% | -$1.62K | ﹤0.01% | 3103 |
|
|
2023
Q4 | $21.7K | Sell |
1,344
-4
| -0.3% | -$65 | ﹤0.01% | 3016 |
|
|
2023
Q3 | $17.1K | Sell |
1,348
-2,076
| -61% | -$26.4K | ﹤0.01% | 2949 |
|
|
2023
Q2 | $48.2K | Sell |
3,424
-894
| -21% | -$12.6K | ﹤0.01% | 2494 |
|
|
2023
Q1 | $66.7K | Sell |
4,318
-151
| -3% | -$2.33K | ﹤0.01% | 2375 |
|
|
2022
Q4 | $73.2K | Sell |
4,469
-371
| -8% | -$6.08K | ﹤0.01% | 2330 |
|
|
2022
Q3 | $90K | Buy |
4,840
+788
| +19% | +$14.7K | ﹤0.01% | 2239 |
|
|
2022
Q2 | $53K | Buy |
4,052
+2,032
| +101% | +$26.6K | ﹤0.01% | 2539 |
|
|
2022
Q1 | $18K | Sell |
2,020
-328
| -14% | -$2.92K | ﹤0.01% | 3134 |
|
|
2021
Q4 | $23K | Buy |
2,348
+367
| +19% | +$3.6K | ﹤0.01% | 3030 |
|
|
2021
Q3 | $68K | Buy |
1,981
+366
| +23% | +$12.6K | ﹤0.01% | 2490 |
|
|
2021
Q2 | $59K | Sell |
1,615
-10,852
| -87% | -$396K | ﹤0.01% | 2585 |
|
|
2021
Q1 | $559K | Sell |
12,467
-76
| -0.6% | -$3.41K | ﹤0.01% | 1432 |
|
|
2020
Q4 | $716K | Buy |
12,543
+1,470
| +13% | +$83.9K | ﹤0.01% | 1259 |
|
|
2020
Q3 | $568K | Buy |
11,073
+8,121
| +275% | +$417K | ﹤0.01% | 1257 |
|
|
2020
Q2 | $176K | Buy |
2,952
+939
| +47% | +$56K | ﹤0.01% | 1810 |
|
|
2020
Q1 | $83K | Buy |
2,013
+730
| +57% | +$30.1K | ﹤0.01% | 2079 |
|
|
2019
Q4 | $80K | Buy |
1,283
+614
| +92% | +$38.3K | ﹤0.01% | 2258 |
|
|
2019
Q3 | $23K | Buy |
+669
| New | +$23K | ﹤0.01% | 2790 |
|